Journal of Experimental and Clinical Cancer Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 14.3 | Q1 | 93.4% | 3.731 | Q1 | 98.4% |
| 2024 | 12.8 | Q1 | 93.6% | 3.328 | Q1 | 98.0% |
| 2023 | 11.4 | Q1 | 90.9% | 2.806 | Q1 | 97.5% |
| 2022 | 11.3 | Q1 | 91.0% | 2.413 | Q1 | 96.9% |
| 2021 | 12.7 | Q1 | 91.2% | 2.350 | Q1 | 96.9% |
| 2020 | — | — | 2.752 | Q1 | 97.5% | |
| 2019 | — | — | 2.127 | Q1 | 96.1% | |
| 2018 | — | — | 1.761 | Q1 | 93.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0392-9078
ISSN
1756-9966
country
GBcoverage
1982-2026